NLRP3 modulator 8-1
NLRP3 modulator 8 (compound 248) is a NLRP3 inhibitor. NLRP3 modulator 8 inhibits LPS (HY-D1056)-induced IL-1β secretion in PMA-differentiated THP-1 cells with an IC50 of 3 nM. NLRP3 modulator 8 can be used in studies related to NLRP3 inflammasome activation and innate immune signaling . .
For research use only. We do not sell to patients.
- CAS No.: 2771020-68-7
- Formula: C18H20FIN2O3
- Molecular Weight:458.27
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
NLRP3 3 nM (IC50) |
NLRP3 modulator 8 (compound 248) (induced with PMA (HY-18739) at 5 ng/mL for 40 h; stimulated with LPS at 25 ng/mL for 2 h; treated for 1 h; stimulated with Nigericin (HY-127019) at 5 μM for 2 h) inhibits IL-1β secretion in THP-1 cells with an IC50 of 3 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 2771020-68-7
-
Molecular Weight 458.27
-
Formula C18H20FIN2O3
-
SMILES
F[C@@H]1[C@]2(C1)C3=CC(I)=CC=C3C(N(C2)CC(N[C@H]4C[C@@](O)(C4)C)=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- NLRP3 modulator 8-1
- 2771020-68-7
- NOD-like Receptor (NLR)
- Interleukin Related
- non-alcoholic steatohepatitis
- chronic infantile neurological cutaneous and articular syndrome
- neonatal-onset multisystem inflammatory disease
- TNF-α-mediated pathways
- gout
- familial Mediterranean fever
- NLRP3
- Muckle-Wells syndrome
- cryopyrin-associated autoinflammatory syndrome
- nonalcoholic fatty liver disease
- Inhibitor
- inhibitor
- inhibit